טוען...
Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk
PURPOSE: Women with a family history of breast cancer are frequently referred for hereditary cancer genetic testing, yet < 10% are found to have pathogenic variants in known breast cancer susceptibility genes. Large-scale genotyping studies have identified common variants (primarily single-nucleo...
שמור ב:
| הוצא לאור ב: | JCO Precis Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of Clinical Oncology
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7446363/ https://ncbi.nlm.nih.gov/pubmed/32923876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.19.00360 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|